Featuring: Massimo Cristofanilli, MD
It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.
Breast cancer survival rates have been improving since the 1990s, but there's still a significant need for new therapies. Every year, more than 40,000 American women die from breast cancer. Dr. Massimo Cristofanilli has exciting results from a phase three clinical trial he led, published in the New England Journal of Medicine, that shows improved survival rates for women with common forms of advanced breast cancer.
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
This podcast was originally release via the Feinberg School of Medicine News Center in December 2018.
Massimo Cristofanilli, MD
Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.